TITLE

The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids

AUTHOR(S)
Forrest, E. H.; Morris, A. J.; Stewart, S.; Phillips, M.; Oo, Y. H.; Fsher, N. C.; Haydon, G.; O'grady, J.; Day, C. P.
PUB. DATE
December 2007
SOURCE
Gut;Dec2007, Vol. 56 Issue 12, p1743
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: There is no consensus on the pharmacological treatment of alcoholic hepatitis. The Glasgow alcoholic hepatitis score (GAHS) has been shown to be more accurate than the modified Maddrey's discriminant function (mDF) in the prediction of outcome from alcoholic hepatitis. This study aimed to determine whether the GAHS was able to identify those patients who would benefit from corticosteroids. Methods: 225 patients with an mDF greater than or equal to 32 from five hospital centres in the United Kingdom were reviewed. Patient survival relative to the GAHS and the use of corticosteroids was recorded. Results: 144 patients with an mDF greater than or equal to 32 (64%) also had a GAHS greater than or equal to 9. There was no difference in survival between untreated or corticosteroid-treated patients for those with a GAHS less than 9. For patients with a GAHS greater than or equal to 9 the 28-day survival for untreated and corticosteroid-treated patients was 52% and 78% (p=0.002), and 84-day survival was 38% and 59% (p = 0.02), respectively. Conclusions: Among patients with an mDF greater than or equal to 32, there was no appreciable benefit from treatment with corticosteroids in patients with a GAHS less than 9. Patients with a GAHS greater than or equal to 9 have an extremely poor prognosis if they are not treated with corticosteroids, or if such treatment is contraindicated.
ACCESSION #
28105581

 

Related Articles

  • Methylprednisolone Therapy in Patients with Severe Alcoholic Hepatitis. Carithers Jr., Robert I.; Herlong, Franklin; Diehl, Anna Mae; Shaw, Ellen W.; Combes, Burton; Fallon, Harold J.; Maddrey, Willis C. // Annals of Internal Medicine;5/1/89, Vol. 110 Issue 9, p685 

    Presents a study that determined the efficiency of a corticosteroid in reducing the short-term mortality of patients with severe alcoholic hepatitis. Design of the study; Setting of the study; Profile of patients; Discussion on the results of the study.

  • Do Corticosteroids Reduce Mortality from Alcoholic Hepatitis? Imperiale, Thomas F.; McCullough, Arthur J. // Annals of Internal Medicine;8/15/90, Vol. 113 Issue 4, p299 

    Presents a study that determined whether corticosteroids affect short-term mortality from alcoholic hepatitis. Overview of alcoholic hepatitis; Criteria used to assess the included trials; Assessment of the statistical validity of aggregating the trials; Mortality rates in treatment and control...

  • THE GLASGOW ALCOHOLIC HEPATITIS SCORE IDENTIFIES PATIENTS LIKELY TO BENEFIT FROM CORTICOSTEROIDS. Forrest, E. H.; Morris, J. M.; Stewart, S.; Day, C. P. // Gut;Apr2004 Supplement 3, Vol. 53, pA13 

    The use of corticosteroids in the treatment acute alcoholic hepatitis remains controversial. Their use has been recommended for patients with a discriminant function. The recently described Glasgow Alcoholic Hepatitis Score (GAHS) appears to have a greater accuracy in predicting patient outcome....

  • CORTICOSTEROIDS AS THERAPEUTIC AGENTS IN LIVER DISEASES. Novick, David M. // American Journal of Gastroenterology;Jan1991, Vol. 86 Issue 1, p30 

    Looks at the status of corticosteroids as therapeutic agents in liver diseases. Factor that hinders the acceptance of corticosteroids in treating liver diseases; Diagnosis of autoimmune chronic active hepatitis which is an established hepatic indication for corticosteroid therapy; Improvements...

  • IDENTIFICATION OF CORTICOSTEROID RESPONDERS IN THE TREATMENT OF ACUTE ALCOHOLIC HEPATITIS. Morris, J.M.; Forrest, E.H. // Gut;Apr2003 Supplement 1, Vol. 52, pA103 

    Up to 60% of patients with acute alcoholic hepatitis (AAH) die within 30 days. Despite numerous trials concerning the use of corticosteroids (CS) for this condition considerable debate remains. In our experience some patients with AAH have a dramatic biochemical response to CS. Aim: The aim of...

  • Alcoholic Hepatitis: Current Management. Spengler, Erin; Dunkelberg, Jeffrey; Schey, Ron // Digestive Diseases & Sciences;Oct2014, Vol. 59 Issue 10, p2357 

    Alcoholic hepatitis is an acute manifestation of alcoholic liver disease with mortality as high as 40-50 % in severe cases. Patients usually have a history of prolonged alcohol abuse with or without a known history of liver disease. Although there is significant range in severity at...

  • Alcoholic Hepatitis. Lucey, Michael R.; Mathurin, Philippe; Morgan, Timothy R. // New England Journal of Medicine;6/25/2009, Vol. 360 Issue 26, p2758 

    The article provides information on alcoholic hepatitis, which is caused by excessive alcohol consumption. It says that alcoholic hepatitis is a clinical syndrome of liver failure and jaundice that develops after decades of heavy alcohol intake. According to the author, one of the major signs of...

  • The Pervading Influence of Alcoholic Liver Disease in Hepatology. Williams, Roger // Alcohol & Alcoholism;Jul/Aug2008, Vol. 43 Issue 4, p393 

    Rising levels of alcohol consumption in the UK are leading to substantial increases in morbidity and mortality from liver disease. Drinking is starting at an earlier age with binging an increasing common pattern, and women are overtaking men in the consumption. Manifestations of liver damage...

  • Exacerbation of Chronic Active Hepatitis Type B after Short-Term Corticosteroid Therapy Resulting in Fatal Liver Failure. Laskus, Tomasz; Slusarczyk, Janusz; Cianciara, Janusz; Loch, Teresa // American Journal of Gastroenterology;Oct1990, Vol. 85 Issue 10, p1414 

    The case of a 36-yr-old male with chronic active type B hepatitis in whom 4-wk prednisone therapy resulted in prolonged and fatal exacerbation of liver disease is described. Thus, short-term corticosteroid therapy may in some patients have disastrous effects on the course of chronic active...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics